Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus
- PMID: 8554908
- DOI: 10.1089/aid.1995.11.1107
Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus
Abstract
Definition of the immunological mechanisms involved in protective immunity against lentiviral infections is crucial to the development of an effective vaccine. The induction of gag- and env-specific cell-mediated immune responses was studied in cats following vaccination with whole inactivated feline immunodeficiency virus (FIV). Cats were immunized by inoculation with three doses of paraformaldehyde-inactivated FIV, derived from the feline lymphoid cell line, FL-4, which is persistently infected with the Petaluma isolate of FIV. Autologous or allogeneic skin fibroblasts either infected with recombinant FIV gag- or env-vaccinia virus or pulsed with FIV env peptides were used as targets in chromium-51 release assays. Effector cells were fresh peripheral blood mononuclear cells. Following the third immunization, all vaccinated cats, but none of the control cats immunized with adjuvant alone, had detectable FIV env-specific lymphocytotoxicity in their peripheral blood. Two cats also exhibited gag-specific activity. There was no recognition of either allogeneic skin fibroblasts infected with recombinant vaccinia virus or autologous target cells infected with wild-type vaccinia virus, indicating the specificity and MHC-restricted nature of the response. Vaccinated cats, but not control cats, were protected from challenge with the homologous Petaluma isolate of FIV. Partial epitope mapping of the env-specific cytotoxic response was performed using overlapping 10-amino acid peptides from the env V3 domain of FIV. This response appeared to be directed at env peptide 1 (RAISSWKQRN) and env peptide 3 (QRNRWEWRPD), which lie adjacent to a beta-turn within the V3 domain.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.J Immunol. 1996 Oct 15;157(8):3658-65. J Immunol. 1996. PMID: 8871667
-
Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.AIDS. 1998 Jan 1;12(1):11-8. doi: 10.1097/00002030-199801000-00002. AIDS. 1998. PMID: 9456250
-
Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide.J Virol. 1994 Sep;68(9):5835-44. doi: 10.1128/JVI.68.9.5835-5844.1994. J Virol. 1994. PMID: 8057464 Free PMC article.
-
Mucosal infection and vaccination against feline immunodeficiency virus.J Biotechnol. 1999 Aug 20;73(2-3):213-21. doi: 10.1016/s0168-1656(99)00139-x. J Biotechnol. 1999. PMID: 10486930 Review.
-
Feline immunodeficiency virus (FIV) neutralization: a review.Viruses. 2011 Oct;3(10):1870-90. doi: 10.3390/v3101870. Epub 2011 Oct 13. Viruses. 2011. PMID: 22069520 Free PMC article. Review.
Cited by
-
Anti-feline immunodeficiency virus (FIV) soluble factor(s) produced from antigen-stimulated feline CD8(+) T lymphocytes suppresses FIV replication.J Virol. 2000 Jan;74(2):676-83. doi: 10.1128/jvi.74.2.676-683.2000. J Virol. 2000. PMID: 10623729 Free PMC article.
-
FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review.Vet Immunol Immunopathol. 2002 Dec;90(3-4):113-32. doi: 10.1016/s0165-2427(02)00227-1. Vet Immunol Immunopathol. 2002. PMID: 12459160 Free PMC article. Review.
-
Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection.J Virol. 1996 Nov;70(11):7561-8. doi: 10.1128/JVI.70.11.7561-7568.1996. J Virol. 1996. PMID: 8892875 Free PMC article.
-
Effect of dual-subtype vaccine against feline immunodeficiency virus infection.Vet Microbiol. 1997 Nov;58(2-4):155-65. doi: 10.1016/s0378-1135(97)00164-8. Vet Microbiol. 1997. PMID: 9453127 Free PMC article.
-
Advances in FIV vaccine technology.Vet Immunol Immunopathol. 2008 May 15;123(1-2):65-80. doi: 10.1016/j.vetimm.2008.01.030. Epub 2008 Jan 20. Vet Immunol Immunopathol. 2008. PMID: 18295907 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous